Amgen Inc (AMGN) earnings · P/E 27, rev $36.75B
These earnings events as JSON? API free 100/dayAmgen Inc (AMGN) is a drug manufacturers - general company listed on US.
This AMGN earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 27.3.
When the next AMGN 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 10.0% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full AMGN research stays on the stock page; the tape stays on the quote page.
AMGN earnings FAQ
What are AMGN's latest revenue and net income?
Latest cached Amgen Inc (AMGN) revenue for Dec 31, 2025 was $36.75B. Net income was $7.71B. Statements: https://lician.com/financials/amgn
What is AMGN's latest diluted EPS?
Latest cached Amgen Inc (AMGN) diluted EPS for Dec 31, 2025 was $14.23.
What period does the latest AMGN earnings print cover?
The latest cached Amgen Inc (AMGN) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did AMGN revenue change from the prior cached period?
Cached Amgen Inc (AMGN) revenue was up 10.0% from $33.42B (Dec 31, 2024) to $36.75B (Dec 31, 2025). Statements: https://lician.com/financials/amgn
What is AMGN's P/E ratio?
Amgen Inc (AMGN) trailing P/E is 27.3 on the latest cached fundamentals snapshot.
Where are AMGN earnings listed?
Cached earnings facts for Amgen Inc (AMGN) are listed at https://lician.com/earnings/amgn. Statements: https://lician.com/financials/amgn
Not investment advice.